Enhancing perifosine's anticancer efficacy by preventing autophagy
1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA. ssun@emory.edu
Abstract:
Our long-term research goal is to develop efficacious regimens for cancer therapy through our understanding of cancer biology and drug mechanisms. Perifosine is an alkylphospholipid exhibiting antitumor activity and is currently being tested in clinical trials. Its activity is partly associated with its ability to inhibit Akt activity. In an effort to understand the mechanism by which perifosine exerts its anticancer activity, our recent work shows that perifosine, in addition to inhibition of Akt, inhibits mTOR signaling through a different mechanism than classical mTOR inhibitors such as rapamycin via facilitating the degradation of major components in the mTOR axis including mTOR, raptor and rictor. Accordingly, perifosine substantially induces autophagy in addition to apoptosis. The combination of perifosine with a lysosomal inhibitor enhances apoptosis and inhibition of the growth of xenografts in nude mice, suggesting that perifosine-induced autophagy protects cells from undergoing apoptosis. Thus, our findings highlight a novel mechanism accounting for perifosine's anticancer activity involving degradation-mediated mTOR inhibition and also suggest a potential strategy to enhance perifosine's anticancer efficacy by preventing autophagy.
Insights
Perifosine, an anticancer drug, inhibits cancer growth by degrading mTOR signaling components, leading to autophagy and apoptosis. Combining perifosine with lysosomal inhibitors enhances its efficacy by blocking protective autophagy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Perifosine is an alkylphospholipid with demonstrated antitumor activity.
- Its mechanism involves Akt inhibition, but further understanding is needed.
- Current research explores its effects on mTOR signaling and cell death pathways.
Purpose of the Study:
- To elucidate the anticancer mechanism of perifosine.
- To investigate perifosine's interaction with mTOR signaling pathway.
- To explore the role of autophagy in perifosine's efficacy.
Main Methods:
- Investigated perifosine's effect on mTOR components (mTOR, raptor, rictor) degradation.
- Assessed induction of autophagy and apoptosis by perifosine.
- Evaluated combination therapy of perifosine with a lysosomal inhibitor in xenograft models.
Main Results:
- Perifosine inhibits mTOR signaling by facilitating the degradation of key mTOR axis components, distinct from rapamycin.
- Perifosine significantly induces both autophagy and apoptosis.
- Combination of perifosine with a lysosomal inhibitor enhanced apoptosis and suppressed tumor growth in vivo.
- Perifosine-induced autophagy appears to protect cancer cells from apoptosis.
Conclusions:
- Perifosine exhibits anticancer activity through a novel mechanism of degradation-mediated mTOR inhibition.
- Autophagy induced by perifosine may confer resistance to apoptosis.
- Inhibiting autophagy could be a viable strategy to potentiate perifosine's therapeutic efficacy in cancer treatment.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Drugs that Stabilize Microtubules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Destabilize Microtubules


